Biotechnology

New patent expiration for Novartis Pharms drug ENTRESTO – DrugPatentWatch

[ad_1]

Copyright © DrugPatentWatch. Originally published in Recently expired patent for the drug Novartis Pharms ENTRESTO

Annual Drug Patent Expiration for ENTRESTO
Annual Drug Patent Expiration for ENTRESTO

Entresto is a drug marketed by Novartis Pharms Corp and included in one NDA. It is available from a single supplier. There are ten patents protecting this drug.

ENTRESTO drug price trends.

Drug patent litigation for ENTRESTO.

This drug has thirty-six patent family members in twenty-seven countries.

The generic ingredient in ENTRESTO is sacubitril; valsartan. One registered supplier for this compound. Additional details are available on sacubitril; valsartan profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published in Recently expired patent for the drug Novartis Pharms ENTRESTO

[ad_2]

Source link

Related Articles

Back to top button